Gujarat Kidney and Super Speciality IPO
Open Date
22 Dec 2025
Close Date
24 Dec 2025
Open Date
22 Dec 2025
Close Date
24 Dec 2025
Min Investment
Lot Size
Issue Size
Price Range
Subscribed

Founded In
2019
CEO
Dr. Bhartiben Pragnesh Bharpoda
Financials of Gujarat Kidney And Super Speciality IPO
| Key Performance Indicators | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating Revenue | 0.00 | 4.77 | 40.24 |
| Other Income | 0.00 | 0.70 | 0.15 |
Total Income | 0.00 | 5.48 | 40.40 |
Total Expenses | 0.01 | 3.21 | 27.63 |
| Profit Before Tax | -0.01 | 2.27 | 12.77 |
Total Profit | -0.01 | 1.71 | 9.50 |
All figures are in crores (₹)

Utilisation of Proceeds
All figures are in crores (₹)
| Purpose | Amount |
|---|---|
| The company proposes to acquire 100% shareholding in Parekhs Hospital Private Limited to expand its footprint in Ahmedabad metropolitan city and leverage existing patient base, staff, infrastructure and operational capabilities. | 77 |
| The company intends to make part payment towards the remaining purchase consideration for the already acquired Ashwini Medical Centre to complete the acquisition process. | 12 |
| The company plans to acquire additional equity shares to make Harmony Medicare Private Limited a wholly-owned subsidiary and strengthen its presence in Bharuch. | 11 |
| The company proposes to construct a new hospital facility dedicated to women's healthcare services in Vadodara to cater to gynecological and infertility related treatments. | 30 |
| The company intends to purchase MAKO SmartRobotics System to enhance its orthopaedics vertical and introduce robotic surgery capabilities at its Vadodara hospital. | 7 |
| The company proposes to repay secured borrowings to reduce outstanding indebtedness, debt servicing costs and maintain favorable debt to equity ratio. | 1 |
| The company plans to utilize funds for strategic acquisitions and general corporate purposes including organic growth opportunities, marketing capabilities and business operations. | - |

- Pre-eminence in renal sciences, with established sub-superspecialities in urology: The company has established six sub-specialties in urology including endourology, urologic oncology, pediatric urology, reconstructive urology, renal transplant, laparoscopic urology and female urology. The company performed 2740 endourology procedures, 200 urologic oncology procedures, and 202 renal transplant procedures across FY 2023-2025 and three months ended June 30, 2025.
- Asset light business model with focus in central region of Gujarat: The company operates through leased properties and acquired operational control in hospitals through minority holdings (51%-90%) without investing in land, building, and medical equipment. The company achieved PAT of ₹ 3109 lakhs, ₹ 11997.46 lakhs, ₹ 10344.15 lakhs and ₹ 8579.19 lakhs for the three month period ended June 30, 2025 and Financial Years 2025, 2024 and 2023 respectively.
- Ability to attract, retain skilled and experienced quality medical professionals: The company maintains low attrition ratios with full time doctors at 2.40%-2.99%, visiting doctors at 2.10%-Nil, and nurses at 0.85%-Nil for FY 2025 and June 30, 2025. As of June 30, 2025, the company employed 89 doctors and 332 nurses with various engagement models including continuing medical education programs.
- Track record of operating and financial performance and growth: The company operates 539 total bed capacity with 389 operational beds and achieved average bed occupancy rate of 54.77% for June 30, 2025. The company generated revenue from operations of ₹ 3109.01 lakhs for three months ended June 30, 2025 with EBITDA margin of 43.76% and PAT margin of 26.87%.
- Experienced and qualified Professional management: The company is led by Dr. Pragnesh Yashwantsingh Bharpoda who holds M.Ch degree in Urology from AIMS Kochi with more than a decade of experience. The management team includes qualified doctors with specialized degrees and decades of experience in their respective fields including completion of more than 15000 surgeries.
- Accreditation of hospital facilities: The company's facilities in Gujarat Kidney and Superspeciality Hospital in Vadodara and Raj Palmland Hospital in Bharuch have received accreditations from the National Accreditation Board for Hospitals and Healthcare Providers (NABH). This accreditation demonstrates the company's focus on quality medical services and commitment to patient care.

